# ExoDx Prostate Evaluation in Prior Negative Prostate Biopsy Setting

> **NCT04357717** · — · TERMINATED · sponsor: **Exosome Diagnostics, Inc.** · enrollment: 150 (actual)

## Conditions studied

- Prostate Cancer

## Interventions

- **DIAGNOSTIC_TEST:** ExoDx Prostate

## Key facts

- **NCT ID:** NCT04357717
- **Lead sponsor:** Exosome Diagnostics, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** TERMINATED
- **Start date:** 2020-03-15
- **Primary completion:** 2021-09-01
- **Final completion:** 2021-09-01
- **Target enrollment:** 150 (ACTUAL)
- **Why stopped:** project reprioritization
- **Last updated:** 2022-03-31


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04357717

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04357717, "ExoDx Prostate Evaluation in Prior Negative Prostate Biopsy Setting". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT04357717. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*